Proyecto de titulación embargado con fines de de publicación de impacto

Abstract

Objective: to describe the characteristics of conjunctivitis as an ophthalmologic manifestation of SARS-CoV-2 in individuals with COVID-19. Methods: an integrative review of articles published between 2020 and 2022 was performed, using the PICO strategy to integrate the research question. Electronic searches were performed in the Pubmed database (https://pubmed.ncbi.nlm.nih.gov/) and ScienceDirect (https://www.sciencedirect.com/), in Spanish or English, using standard use of descriptors and Boolean operators AND and OR. An electronic search was performed to describe the characteristics of conjunctivitis as an ophthalmologic manifestation of SARS-CoV-2 in individuals with COVID-19. Results: A total record of 96 articles was identified, including 14 studies of patients with SARS-CoV-2 conjunctivitis as a manifestation of COVID-19. Conjunctivitis as an ophthalmologic manifestation of SARS-CoV-2 in individuals with COVID-19 occurs with a prevalence of 0.8% to 31.6%. The most common features are conjunctival hyperemia, epiphora, foreign body sensation and photophobia. Conclusion: Conjunctivitis can be an initial part of the clinical picture of COVID-19, or it can even manifest as the only symptom that appears days before, the incidence and characteristics of conjunctivitis as an ophthalmologic manifestation of COVID-19 are variable.